Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim
Open Access
- 10 June 2016
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 12 (1) , 1-6
Abstract
Immune thrombocytopenia (ITP) in dogs is analogous to that in humans. Romiplostim, a novel thrombopoietin receptor (TPO-R) agonist, is currently used for the treatment of refractory ITP in humans, but not in dogs. Here, we describe the response to romiplostim in five dogs with refractory ITP. Five dogs with severe and refractory ITP (three primary and two secondary) received romiplostim subcutaneously. Four dogs were administered 3–5 μg/kg and one dog received 10–13 μg/kg body weight once weekly. Romiplostim was well-tolerated and administration was associated with an increase in platelet counts in all five dogs. Four of the five dogs entered remission and relapses were not observed over a follow-up period of 3–10 months. Romiplostim is effective in the treatment of ITP in dogs at least as well as in humans. This finding may help to develop and use new therapeutics for ITP in dogs and humans.Keywords
Funding Information
- German Research Foundation (DFG) (SA 405/3-1)
This publication has 37 references indexed in Scilit:
- Treatment and predictors of outcome in dogs with immune-mediated thrombocytopeniaJournal of the American Veterinary Medical Association, 2011
- Romiplostim or Standard of Care in Patients with Immune ThrombocytopeniaNew England Journal of Medicine, 2010
- Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedsideBritish Journal of Haematology, 2010
- The ITP syndrome: pathogenic and clinical diversityBlood, 2009
- A rationally designed agonist antibody fragment that functionally mimics thrombopoietinProceedings of the National Academy of Sciences, 2006
- Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancyBritish Journal of Haematology, 2003
- Canine Idiopathic Thrombocytopenic PurpuraJournal of Veterinary Internal Medicine, 1996
- Therapy of Immune Mediated ThrombocytopeniaJournal of Veterinary Internal Medicine, 1990
- Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.Journal of Clinical Investigation, 1987
- Immune ThrombocytopeniaNew England Journal of Medicine, 1979